Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.
- Emily Stephenson
- Gary Reynolds
- Muzlifah Haniffa